Form 8.3 - DECHRA PHARMACEUTICALS PLC

Barclays PLC
17 August 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Aug 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

 

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

3,712,151

3.26%

2,088,119

1.83%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

2,070,225

1.82%

3,644,951

3.20%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

5,782,376

5.08%

5,733,070

5.03%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

13,605

37.9864  GBP

1p ordinary

Purchase

4,944

37.9905  GBP

1p ordinary

Sale

131,489

37.9810  GBP

1p ordinary

Purchase

4,874

37.9800  GBP

1p ordinary

Sale

14,332

37.9800  GBP

1p ordinary

Sale

8,000

37.9773  GBP

1p ordinary

Sale

10,289

37.9600  GBP

1p ordinary

Purchase

6,000

37.9943  GBP

1p ordinary

Purchase

4,128

37.9700  GBP

1p ordinary

Sale

9,916

37.9785  GBP

1p ordinary

Purchase

4,516

37.9900  GBP

1p ordinary

Purchase

100,134

37.9789  GBP

1p ordinary

Purchase

5,326

37.9912  GBP

1p ordinary

Sale

302

38.0000  GBP

1p ordinary

Purchase

206,807

37.9991  GBP

1p ordinary

Sale

9,277

37.9653  GBP

1p ordinary

Sale

6,848

37.9665  GBP

1p ordinary

Sale

4,128

37.9700  GBP

1p ordinary

Purchase

422

38.0000  GBP

1p ordinary

Purchase

2,921

37.9781  GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

CFD

Long

1

37.9800  GBP

1p ordinary

SWAP

Long

8,000

37.9773  GBP

1p ordinary

SWAP

Long

9,916

37.9785  GBP

1p ordinary

SWAP

Long

10,651

37.9688  GBP

1p ordinary

SWAP

Long

15,763

37.9600  GBP

1p ordinary

SWAP

Long

131,489

37.9810  GBP

1p ordinary

SWAP

Short

134

37.9789  GBP

1p ordinary

CFD

Short

302

38.0000  GBP

1p ordinary

SWAP

Short

403

38.0030  GBP

1p ordinary

SWAP

Short

1,700

37.9808  GBP

1p ordinary

SWAP

Short

1,901

37.9800  GBP

1p ordinary

SWAP

Short

6,000

37.9943  GBP

1p ordinary

SWAP

Short

19,843

37.9893  GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i)  the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Aug 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings